Indian pharma stocks fall as Trump moves to cut U.S. drug prices
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 12 2025
0mins
Source: Reuters
Impact of U.S. Drug Price Cuts on Indian Pharma Stocks: Indian pharmaceutical stocks fell 1.6% following President Trump's announcement to cut drug prices by 30%-80%, with significant declines in companies like Sun Pharma and Biocon, despite broader market gains.
Potential Consequences for Indian Drugmakers: Analysts warn that a substantial price reduction in the U.S. could negatively affect the market for both branded and generic drugs, impacting Indian companies that rely heavily on U.S. sales, which constitute nearly a third of India's pharma exports.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
